AKBA-10K-20161231

Company

Akebia Therapeutics, Inc.

Filed

March 6, 2017

Period of Report

December 31, 2016

Accession Number

0001564590-17-003466

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →